In this sense, SFRP5 and WNT5A of VAT seem to be able to play relevant roles in the pathogenesis of NAFLD given the implication of this tissue in the adipokine and free fatty acid delivery into portal-vein circulation [12]. This evidence concerns the gene SFRP5 and metabolic dysfunction-associated steatotic liver disease.